Schouffoer Anne A, van der Giesen Florus J, Beaart-van de Voorde Liesbeth J J, Wolterbeek Ron, Huizinga Tom W J, Vliet Vlieland Theodora P M
Department of Rheumatology, Leiden University Medical Center, Department of Rheumatology, Haga Teaching Hospital, The Hague,
Department of Rheumatology, Haga Teaching Hospital, The Hague.
Rheumatology (Oxford). 2016 Aug;55(8):1386-93. doi: 10.1093/rheumatology/kew016. Epub 2016 Apr 12.
The aim was to assess the validity and responsiveness of the Michigan Hand Questionnaire (MHQ) in patients with SSc.
Data were gathered in connection with a randomized, controlled trial comparing the effectiveness of a 12-week multidisciplinary team care programme, including a hand function treatment module, with regular care. Hand function was evaluated by the MHQ (37 items, six domains: Function, Daily activities, Pain, Work, Aesthetics and Satisfaction) and other measurements, including the HAQ, Hand Mobility in Scleroderma, Sequential Occupational Dexterity Assessment (SODA), grip strength, pinch grip and modified Rodnan Skin Score. Fifty-three patients (28 intervention group and 25 control group) completed evaluation at baseline and after 12 weeks. Validity was determined by computing Spearman correlation coefficients between the baseline MHQ total score and subscales and other measures of (hand) disability. Responsiveness in the intervention group was evaluated by the standardized response mean and effect size (ES). In addition, the pooled ES for the difference between the two groups was computed.
Significant correlations were seen between the MHQ total score and the HAQ (r = -0.62), Hand Mobility in Scleroderma (r = -0.54), SODA (r = 0.47), SODA Pain (r = 0.32) and modified Rodnan Skin Score (r = 0.46). The ES of the MHQ total score within the intervention group was 0.49, which was larger than that of all other outcome measures. Similar results were obtained for the standardized response mean. The pooled ES of the difference between intervention and control groups for the MHQ total score was 0.86.
The MHQ demonstrated adequate validity and responsiveness in patients with SSc.
旨在评估密歇根手部问卷(MHQ)在系统性硬化症(SSc)患者中的有效性和反应性。
收集与一项随机对照试验相关的数据,该试验比较了为期12周的多学科团队护理计划(包括手部功能治疗模块)与常规护理的有效性。通过MHQ(37项,六个领域:功能、日常活动、疼痛、工作、美观和满意度)以及其他测量方法评估手部功能,其他测量方法包括健康评估问卷(HAQ)、硬皮病手部活动度、连续职业灵巧性评估(SODA)、握力、捏力和改良Rodnan皮肤评分。53名患者(28名干预组和25名对照组)在基线和12周后完成评估。通过计算基线MHQ总分与分量表以及其他(手部)残疾测量指标之间的Spearman相关系数来确定有效性。通过标准化反应均值和效应量(ES)评估干预组的反应性。此外,计算两组之间差异的合并效应量。
MHQ总分与HAQ(r = -0.62)、硬皮病手部活动度(r = -0.54)、SODA(r = 0.47)、SODA疼痛(r = 0.32)和改良Rodnan皮肤评分(r = 0.46)之间存在显著相关性。干预组内MHQ总分的效应量为0.49,大于所有其他结局指标。标准化反应均值也得到了类似结果。干预组与对照组之间MHQ总分差异的合并效应量为0.86。
MHQ在SSc患者中显示出足够的有效性和反应性。